Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact

PRODUCT LITERATURE

Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact

Krzesinski JM - Personal Name;

This review analyses one of these strategies, which is the development of effective and safe combination therapy. Indeed, at least two antihypertensive agents are often needed to achieve blood pressure control. Exforge® (Novartis) is a new drug combination of the calcium channel blocker, amlodipine, and the angiotensin II receptor blocker, valsartan

Availability

Location name is not set Location name is not set

TENSIVASKDUO-005

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Hypertension
Tensivask Duo
Amlodipine/valsartan combination
Exforge®
Specific Detail Info: Core Evidence 2009:4 1–11
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment